Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The first primary research objective of the study is to determine whether high-fat load (150 g of fat) induces increase in hepatic fat content (HFC) three and six hours after meal in insulin-sensitive subjects with normal HFC (<5% of fat) and in non-diabetic subjects with an increased HFC (>5% of fat). Furthermore, the other objective of the study is to determine whether the response of HFC to a high-fat load is affected by coadministration of glucose or fructose.
The epidemic of non-alcoholic fatty liver disease (NAFLD) is becoming a major challenge faced by health system worldwide. The hepatic fat comes from the major sources - non-esterified fatty acids (NEFA) released from adipose tissue, dietary fat and de novo lipogenesis. Fat accumulation in the liver then occurs when triglycerides (TG) that are formed are not rapidly enough oxidized or secreted from the liver in very low density lipoproteins (VLDL). It can be hypothesized that the capacity of the liver to eliminate TG can be overcome after high load of dietary fat. High-fat load should induce an immediate accumulation of hepatic fat that could be detected using 1H magnetic resonance spectroscopy (1H-MRS). The accumulation of liver fat can be also affected by coadministration of simple carbohydrates - glucose and fructose. The administration of these carbohydrates can have a pronounced impact on the availability of particular sources of hepatic fat.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy subjects, Fat | Experimental | non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) - high-fat load intervention |
|
| Steatosis, Fat | Experimental | non-obese non-diabetic male volunteers with hepatosteatosis (more than 5% of liver fat) - high-fat load intervention |
|
| Healthy subjects, Fasting | Other | non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) - fasting |
|
| Steatosis, Fasting | Other | non-obese non-diabetic male volunteers with hepatosteatosis (more than 5% of liver fat) - fasting |
|
| Healthy subjects, Fat+Glucose | Experimental | non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) - high-fat load + glucose administration |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fat | Dietary Supplement | Subjects will consume dairy cream (150 g of fat) at time 0 hours. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Hepatic fat content | Change in hepatic fat content as determined by proton magnetic resonance spectroscopy (%) between 0 and 6 hours | Before time 0 hour, 3 hours, 6 hours |
| Measure | Description | Time Frame |
|---|---|---|
| TG | Plasma triglyceride concentration | before 0, 0.5, 1, 2, 2.5, 3, 4, 4.5, 5, and 6 hours |
| NEFA | Plasma non-esterified fatty-acid concentration |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Milan Hajek, DSc | Institute for Clinical and Experimental Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institute for Clinical and Experimental Medicine | Prague | 14021 | Czechia |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31136656 | Derived | Dusilova T, Kovar J, Drobny M, Sedivy P, Dezortova M, Poledne R, Zemankova K, Hajek M. Different acute effects of fructose and glucose administration on hepatic fat content. Am J Clin Nutr. 2019 Jun 1;109(6):1519-1526. doi: 10.1093/ajcn/nqy386. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Sep 14, 2018 | Sep 19, 2018 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Sep 14, 2018 | Sep 19, 2018 | SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D018955 | CD36 Antigens |
| C407088 | Angptl4 protein, mouse |
| D005947 | Glucose |
| D005632 | Fructose |
| ID | Term |
|---|---|
| D010980 | Platelet Membrane Glycoproteins |
| D008562 | Membrane Glycoproteins |
| D006023 | Glycoproteins |
| D006001 | Glycoconjugates |
Not provided
Not provided
10 non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) and 10 non-obese non-diabetic subjects with increased hepatic fat content (more than 5% of hepatic fat) will undergo series of six experiments - changes of liver fat content will be measured at time 0, 3 and 6 hours after specific dietary interventions
Not provided
Not provided
Not provided
Not provided
| Steatosis, Fat+Glucose |
| Experimental |
non-obese non-diabetic male volunteers with hepatosteatosis (more than 5% of liver fat) - high-fat load + glucose administration |
|
| Healthy subjects, Glucose | Experimental | non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) - glucose administration |
|
| Steatosis, Glucose | Experimental | non-obese non-diabetic male volunteers with hepatosteatosis (more than 5% of liver fat) - glucose administration |
|
| Healthy subjects, Fat+Fructose | Experimental | non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) - high-fat load + fructose administration |
|
| Steatosis, Fat+Fructose | Experimental | non-obese non-diabetic male volunteers with hepatosteatosis (more than 5% of liver fat) - high-fat load + fructose administration |
|
| Healthy subjects, Fructose | Experimental | non-obese insulin-sensitive male volunteers with normal hepatic fat content (less than 5% of liver fat) - fructose administration |
|
| Steatosis, Fructose | Experimental | non-obese non-diabetic male volunteers with hepatosteatosis (more than 5% of liver fat) - fructose administration |
|
| Fasting | Dietary Supplement | Subjects will fast throughout the experiment. |
|
| Fat+Glucose | Dietary Supplement | Subjects will consume dairy cream (150 g of fat) at time 0 hours. At the same time and 2 and 4 hours later they will drink herbal tea containing 50 g of glucose. |
|
| Glucose | Dietary Supplement | Subjects will drink herbal tea containing 50 g of glucose at times 0, 2 and 4 hours. |
|
| Fat+Fructose | Dietary Supplement | Subjects will consume dairy cream (150 g of fat) at time 0 hours. At the same time and 2 and 4 hours later they will drink herbal tea containing 50 g of fructose. |
|
| Fructose | Dietary Supplement | Subjects will drink herbal tea containing 50 g of fructose at times 0, 2 and 4 hours. |
|
| before 0, 0.5, 1, 2, 2.5, 3, 4, 4.5, 5, and 6 hours |
| Glucose | Plasma glucose concentration | before 0, 0.5, 1, 2, 2.5, 3, 4, 4.5, 5, and 6 hours |
| Insulin | Plasma insulin concentration | before 0, 0.5, 1, 2, 2.5, 3, 4, 4.5, 5, and 6 hours |
| Glucagon | Plasma glucagon concentration | before 0, 0.5, 1, 2, 2.5, 3, 4, 4.5, 5, and 6 hours |
| D002241 |
| Carbohydrates |
| D050612 | Fatty Acid Transport Proteins |
| D026901 | Membrane Transport Proteins |
| D002352 | Carrier Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D008565 | Membrane Proteins |
| D011956 | Receptors, Cell Surface |
| D011971 | Receptors, Immunologic |
| D051122 | Scavenger Receptors, Class B |
| D051116 | Receptors, Scavenger |
| D011973 | Receptors, LDL |
| D018110 | Receptors, Lipoprotein |
| D006601 | Hexoses |
| D009005 | Monosaccharides |
| D000073893 | Sugars |
| D007661 | Ketoses |